For research use only
| Cat No. | ABC-X0020C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The SLC34A2-ROS1 (D2033N) BAF3 Cell Line helps evaluate resistance to ROS1 inhibitors and explore novel treatments in the lung cancer research.
The SLC34A2 ROS1 (D2033N) BAF3 Cell Line expresses the human SLC34A2-ROS1 fusion gene carrying a D2033N resistance mutation. Generated via lentiviral integration, this model recapitulates ROS1 fusion-driven oncogenesis with acquired resistance.
Target
The SLC34A2-ROS1 fusion encodes a constitutively active receptor tyrosine kinase implicated in NSCLC. The D2033N mutation confers resistance to ROS1 inhibitors like crizotinib by altering the kinase domain. This model aids in dissecting resistance mechanisms and evaluating next-generation inhibitors. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0020C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The SLC34A2 ROS1 (D2033N) BAF3 Cell Line enables screening of ROS1 inhibitors, elucidation of resistance pathways, and mechanistic studies of ROS1-driven oncogenesis, particularly in lung cancer settings.